Alzheimer's Disease Theranostics

Table of Contents

1. Introduction: Alzheimer's Disease Pathology and Therapeutics 2. Early Diagnosis of Alzheimer's Disease: Pros and Cons 3. Antioxidants in Alzheimer's Therapy 4. Natural Compounds in the Treatment of Alzheimer's Disease 5. Blood Brain Barrier 6. Gene Therapy: The Cornerstone in the Development of Alzheimer's Disease Therapeutics 7. Viral vector therapeutics against Alzheimer's Disease 8. Mitochondria-Targeted Nanoparticles: A Milestone or a Mirage in the Treatment of Alzheimer's Disease 9. Nanoparticles: The Double-Edged Swords 10. Alzheimer Therapeutics: Pros and Cons

Authors

Magisetty Obulesu Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. Magisetty Obulesu is a research associate at the Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. He has 20 years of research and teaching experience. He is also an editorial board of nanotechnology journals including SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science. His research areas include food science, pathology of neurodegenerative diseases such as Alzheimer's disease, designing polymer-based biomaterials such as hydrogels, and development of metal chelators to overcome metal induced toxicity. He has researched Alzheimer's disease and developed an aluminium-induced neurotoxicity rabbit model. Mr. Obulesu's present research focuses on development of redox-active injectable hydrogels of polyion complex. He has written three books and edited two more; he is also the first and corresponding author for majority of his articles.